Authors:
LIU Q
WEINSHENKER BG
WINGERCHUK DM
SOMMER SS
Citation: Q. Liu et al., DENATURATION FINGERPRINTING - 2 RELATED MUTATION DETECTION METHODS ESPECIALLY ADVANTAGEOUS FOR HIGH G+C REGIONS, BioTechniques, 24(1), 1998, pp. 140
Authors:
NOSEWORTHY JH
OBRIEN PC
PETTERSON TM
WEINSHENKER BG
CROSS SA
LEAVITT JA
WEIS JA
STEVENS LN
AUGER RG
RODRIGUEZ M
Citation: Jh. Noseworthy et al., IMMUNOGLOBULIN ADMINISTRATION DOES NOT REVERSE VISUAL-ACUITY LOSS IN LONG-STANDING OPTIC NEURITIS ASSOCIATED WITH MULTIPLE-SCLEROSIS, Annals of neurology, 44(3), 1998, pp. 247-247
Authors:
STEPANEK J
CATALDO SA
EBERSOLD MJ
LINDOR NM
JENKINS RB
UNNI K
WEINSHENKER BG
RUBENSTEIN RL
Citation: J. Stepanek et al., FAMILIAL CHORDOMA WITH PROBABLE AUTOSOMAL-DOMINANT INHERITANCE, American journal of medical genetics, 75(3), 1998, pp. 335-336
Authors:
WEINSHENKER BG
SANTRACH P
BISSONET AS
MCDONNELL SK
SCHAID D
MOORE SB
RODRIGUEZ M
Citation: Bg. Weinshenker et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ALLELES AND THE COURSE AND OUTCOME OF MS - A POPULATION-BASED STUDY, Neurology, 51(3), 1998, pp. 742-747
Authors:
WEINSHENKER BG
HEBRINK D
WINGERCHUK DM
MCMURRAY CT
Citation: Bg. Weinshenker et al., A COMPREHENSIVE SCREEN OF THE TUMOR-NECROSIS-FACTOR RECEPTOR-1 (TNFR1) GENE IN PATIENTS WITH MS, Neurology, 50(4), 1998, pp. 1073-1073
Authors:
NOSEWORTHY JH
WEINSHENKER BG
OBRIEN PC
WEIS JA
PETTERSON TM
WINDEBANK AJ
WHISNANT JP
STOLPSMITH KA
HARPER CM
ROMME LJ
JOHNSON M
AN KN
RODRIGUEZ M
Citation: Jh. Noseworthy et al., INTRAVENOUS IMMUNOGLOBULIN DOES NOT REVERSE RECENTLY ACQUIRED, APPARENTLY PERMANENT WEAKNESS IN MULTIPLE-SCLEROSIS, Annals of neurology, 42(3), 1997, pp. 115-115
Authors:
WEINSHENKER BG
WINGERCHUK DM
LIU Q
BISSONET AS
SCHAID DJ
SOMMER SS
Citation: Bg. Weinshenker et al., GENETIC-VARIATION IN THE TUMOR-NECROSIS-FACTOR-ALPHA GENE AND THE OUTCOME OF MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 378-385
Authors:
WINGERCHUK D
LIU Q
SOBELL J
SOMMER S
WEINSHENKER BG
Citation: D. Wingerchuk et al., A POPULATION-BASED CASE-CONTROL STUDY OF THE TUMOR-NECROSIS-FACTOR ALPHA-308 POLYMORPHISM IN MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 626-628
Citation: Dm. Wingerchuk et al., CLINICAL OUTCOME MEASURES AND RATING-SCALES IN MULTIPLE-SCLEROSIS TRIALS, Mayo Clinic proceedings, 72(11), 1997, pp. 1070-1079
Citation: Bg. Weinshenker et al., METAANALYSIS OF THE PLACEBO-TREATED GROUPS IN CLINICAL-TRIALS OF PROGRESSIVE MS, Neurology, 46(6), 1996, pp. 1613-1619
Authors:
WEINSHENKER BG
WINGERCHUK DM
LIU Q
SCHAID D
SOMMER S
Citation: Bg. Weinshenker et al., DIRECT GENOMIC SEQUENCING TO IDENTIFY GENETIC VARIATIONS ASSOCIATED WITH THE COURSE AND OUTCOME OF MULTIPLE-SCLEROSIS, Neurology, 46(2), 1996, pp. 34005-34005
Citation: Bg. Weinshenker et al., LONG-TERM AND SHORT-TERM OUTCOME OF MULTIPLE-SCLEROSIS - A 3-YEAR FOLLOW-UP-STUDY, Archives of neurology, 53(4), 1996, pp. 353-358
Citation: Ec. Vamvakas et al., METAANALYSIS OF CLINICAL-STUDIES OF THE EFFICACY OF PLASMA-EXCHANGE IN THE TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Journal of clinical apheresis, 10(4), 1995, pp. 163-170
Authors:
THORLAND EC
WEINSHENKER BG
LIU JZ
KETTERLING RP
VIELHABER EL
KASPER CK
AMBRIZ R
PAREDES R
SOMMER SS
Citation: Ec. Thorland et al., MOLECULAR EPIDEMIOLOGY OF FACTOR-IX GERMLINE MUTATIONS IN MEXICAN HISPANICS - PATTERN OF MUTATION AND POTENTIAL FOUNDER EFFECTS, Thrombosis and haemostasis, 74(6), 1995, pp. 1416-1422
Citation: Ec. Vamvakas et al., METAANALYSIS OF CLINICAL-STUDIES OF THE EFFICACY OF PLASMA-EXCHANGE IN THE TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Transfusion, 35(10), 1995, pp. 214-214
Authors:
WEINSHENKER BG
SANTRACH P
SCHAID D
RODRIGUEZ M
Citation: Bg. Weinshenker et al., ASSOCIATION BETWEEN CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX POLYMORPHISMS AND THE COURSE OF MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 384-384